• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国的多次新冠疫情浪潮和疫苗有效性。

Multiple COVID-19 Waves and Vaccination Effectiveness in the United States.

机构信息

Department of Applied Mathematics, The Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Int J Environ Res Public Health. 2022 Feb 17;19(4):2282. doi: 10.3390/ijerph19042282.

DOI:10.3390/ijerph19042282
PMID:35206474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871705/
Abstract

(1) Background: The coronavirus 2019 (COVID-19) pandemic has caused multiple waves of cases and deaths in the United States (US). The wild strain, the Alpha variant (B.1.1.7) and the Delta variant (B.1.617.2) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were the principal culprits behind these waves. To mitigate the pandemic, the vaccination campaign was started in January 2021. While the vaccine efficacy is less than 1, breakthrough infections were reported. This work aims to examine the effects of the vaccination across 50 US states and the District of Columbia. (2) Methods: Based on the classic Susceptible-Exposed-Infectious-Recovered (SEIR) model, we add a delay class between infectious and death, a death class and a vaccinated class. We compare two special cases of our new model to simulate the effects of the vaccination. The first case expounds the vaccinated individuals with full protection or not, compared to the second case where all vaccinated individuals have the same level of protection. (3) Results: Through fitting the two approaches to reported COVID-19 deaths in all 50 US states and the District of Columbia, we found that these two approaches are equivalent. We calculate that the death toll could be 1.67-3.33 fold in most states if the vaccine was not available. The median and mean infection fatality ratio are estimated to be approximately 0.6 and 0.7%. (4) Conclusions: The two approaches we compared were equivalent in evaluating the effectiveness of the vaccination campaign in the US. In addition, the effect of the vaccination campaign was significant, with a large number of deaths averted.

摘要

(1)背景:2019 年冠状病毒病(COVID-19)大流行在美国(美国)造成多波病例和死亡。野生株、阿尔法变异株(B.1.1.7)和德尔塔变异株(B.1.617.2)是这些波的主要罪魁祸首。为了减轻大流行,疫苗接种运动于 2021 年 1 月开始。尽管疫苗效力低于 1,但已报告突破性感染。这项工作旨在研究 50 个美国州和哥伦比亚特区的疫苗接种效果。(2)方法:基于经典的易感-暴露-感染-恢复(SEIR)模型,我们在感染和死亡之间添加了一个延迟类,一个死亡类和一个接种疫苗类。我们比较了我们新模型的两个特殊情况来模拟疫苗接种的效果。第一种情况阐述了接种疫苗的个人是否有完全的保护,而第二种情况是所有接种疫苗的个人都有相同水平的保护。(3)结果:通过将这两种方法应用于报告的美国所有 50 个州和哥伦比亚特区的 COVID-19 死亡病例,我们发现这两种方法是等效的。我们计算,如果没有疫苗,大多数州的死亡人数可能会增加 1.67-3.33 倍。估计中位和平均感染病死率约为 0.6%和 0.7%。(4)结论:我们比较的两种方法在评估美国疫苗接种运动的效果方面是等效的。此外,疫苗接种运动的效果显著,避免了大量死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/49bb5ffb5836/ijerph-19-02282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/afb491390989/ijerph-19-02282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/14734a0d1d49/ijerph-19-02282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/f190c9c61f02/ijerph-19-02282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/49bb5ffb5836/ijerph-19-02282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/afb491390989/ijerph-19-02282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/14734a0d1d49/ijerph-19-02282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/f190c9c61f02/ijerph-19-02282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d5/8871705/49bb5ffb5836/ijerph-19-02282-g004.jpg

相似文献

1
Multiple COVID-19 Waves and Vaccination Effectiveness in the United States.美国的多次新冠疫情浪潮和疫苗有效性。
Int J Environ Res Public Health. 2022 Feb 17;19(4):2282. doi: 10.3390/ijerph19042282.
2
Two waves of COIVD-19 in Brazilian cities and vaccination impact.巴西城市的两波 COVID-19 疫情和疫苗接种的影响。
Math Biosci Eng. 2022 Mar 9;19(5):4657-4671. doi: 10.3934/mbe.2022216.
3
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
4
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
5
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
6
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
7
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.接种严重急性呼吸综合征冠状病毒 2 载体疫苗和基于 mRNA 的疫苗后,一家三级保健医院工作人员的疫苗接种后感染。
Clin Microbiol Infect. 2022 Apr;28(4):596-601. doi: 10.1016/j.cmi.2021.11.023. Epub 2021 Dec 13.
8
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动,以预防感染、住院和死亡:一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
9
Will vaccine-derived protective immunity curtail COVID-19 variants in the US?疫苗衍生的保护性免疫能否在美国遏制新冠病毒变种?
Infect Dis Model. 2021;6:1110-1134. doi: 10.1016/j.idm.2021.08.008. Epub 2021 Sep 9.
10
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.COVID-19 疫苗对 Delta AY.4.2 引起的有症状 SARS-CoV-2 感染和重症 COVID-19 的有效性:苏格兰 540 万人的队列和阴性测试研究。
J Glob Health. 2022 Jul 9;12:05025. doi: 10.7189/jogh.12.05025.

引用本文的文献

1
Charity coverage and decreased COVID-19 mortality among uninsured patients in Texas: A retrospective cohort study.德克萨斯州未参保患者的慈善医保覆盖情况与新冠病毒疾病死亡率降低:一项回顾性队列研究
PLoS One. 2025 Sep 10;20(9):e0330533. doi: 10.1371/journal.pone.0330533. eCollection 2025.
2
SIRI+Q model with a limited capacity of isolation.具有有限隔离能力的SIRI+Q模型。
Theory Biosci. 2025 Mar 29. doi: 10.1007/s12064-025-00437-8.
3
Evaluating the effectiveness of vaccination campaigns: Insights from unvaccinated mortality data.评估疫苗接种运动的效果:来自未接种疫苗者死亡率数据的见解。

本文引用的文献

1
A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.一种简单的模型,用于估计 SARS-COV-2 的 Beta、Delta 和 Omicron 变体在南非的传播能力。
Math Biosci Eng. 2022 Jul 22;19(10):10361-10373. doi: 10.3934/mbe.2022485.
2
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant.基于模型对新冠病毒P.1变体的传播性和再感染情况的估计。
Commun Med (Lond). 2021 Nov 15;1:48. doi: 10.1038/s43856-021-00048-6. eCollection 2021.
3
The Second Wave of COVID-19 in South and Southeast Asia and the Effects of Vaccination.
Infect Dis Model. 2024 Dec 5;10(1):365-373. doi: 10.1016/j.idm.2024.12.004. eCollection 2025 Mar.
4
Quantifying indirect and direct vaccination effects arising in the SIR model.量化 SIR 模型中出现的间接和直接疫苗接种效果。
J R Soc Interface. 2024 Sep;21(218):20240299. doi: 10.1098/rsif.2024.0299. Epub 2024 Sep 18.
5
Estimate the number of lives saved by a SARS-CoV-2 vaccination campaign in six states in the United States with a simple model.用一个简单的模型估算美国六个州开展的新冠病毒疫苗接种活动挽救的生命数量。
IJID Reg. 2024 Jun 15;12:100390. doi: 10.1016/j.ijregi.2024.100390. eCollection 2024 Sep.
6
A comparative study between first three waves of COVID-19 pandemic with respect to risk factors, initial clinic-demographic profile, severity and outcome.关于新冠疫情前三波在风险因素、初始临床人口统计学特征、严重程度和结局方面的比较研究。
J Family Med Prim Care. 2024 Jun;13(6):2455-2461. doi: 10.4103/jfmpc.jfmpc_1884_23. Epub 2024 Jun 14.
7
Assessing the prognostic utility of clinical and radiomic features for COVID-19 patients admitted to ICU: challenges and lessons learned.评估入住重症监护病房的COVID-19患者临床和影像组学特征的预后效用:挑战与经验教训。
Harv Data Sci Rev. 2024 Winter;6(1). doi: 10.1162/99608f92.9d86a749. Epub 2024 Jan 31.
8
Relationship between on-demand telehealth visits and emergency department and hospital surge during the COVID-19 pandemic.2019年冠状病毒病大流行期间按需远程医疗就诊与急诊科及医院负荷激增之间的关系。
J Am Coll Emerg Physicians Open. 2024 Feb 27;5(2):e13128. doi: 10.1002/emp2.13128. eCollection 2024 Apr.
9
What Influence Could the Acceptance of Visitors Cause on the Epidemic Dynamics of a Reinfectious Disease?: A Mathematical Model.访客的接纳会对传染病的疫情动态产生何种影响?:一个数学模型。
Acta Biotheor. 2024 Feb 25;72(1):3. doi: 10.1007/s10441-024-09478-w.
10
Correlation of severity & clinical outcomes of COVID-19 with virus variants: A prospective, multicentre hospital network study.新型冠状病毒肺炎严重程度及临床结局与病毒变异的相关性:一项前瞻性、多中心医院网络研究。
Indian J Med Res. 2024 Jan 1;159(1):91-101. doi: 10.4103/ijmr.ijmr_1041_23. Epub 2024 Mar 4.
南亚和东南亚的新冠疫情第二波及疫苗接种的影响
Front Med (Lausanne). 2021 Dec 14;8:773110. doi: 10.3389/fmed.2021.773110. eCollection 2021.
4
GISAID's Role in Pandemic Response.全球流感共享数据库(GISAID)在大流行应对中的作用。
China CDC Wkly. 2021 Dec 3;3(49):1049-1051. doi: 10.46234/ccdcw2021.255.
5
Forecast of the COVID-19 trend in India: A simple modelling approach.印度新冠疫情趋势预测:一种简单的建模方法。
Math Biosci Eng. 2021 Nov 5;18(6):9775-9786. doi: 10.3934/mbe.2021479.
6
Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism.肯尼亚 COVID-19 传播的数学建模:具有再感染传播机制的模型。
Comput Math Methods Med. 2021 Oct 16;2021:5384481. doi: 10.1155/2021/5384481. eCollection 2021.
7
Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine.与 SARS-CoV-2 突破性感染相关的时间。
Nat Commun. 2021 Nov 4;12(1):6379. doi: 10.1038/s41467-021-26672-3.
8
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers.在医护人员中,感染新冠病毒阿尔法变异株的突破性病例通常无症状或症状轻微。
Nat Commun. 2021 Oct 15;12(1):6032. doi: 10.1038/s41467-021-26154-6.
9
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study.基线 SARS-CoV-2 抗体状况对症状监测和随后 COVID-19 风险的影响——一项前瞻性多中心队列研究。
BMC Med. 2021 Oct 14;19(1):270. doi: 10.1186/s12916-021-02144-9.
10
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性:一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.